European Declaration on Allergen Immunotherapy

Monday, 29 August 2011 10:45

The European Academy of Allergy and Clinical Immunology (EAACI) has released a declaration on allergen immunotherapy in which they urge policy-makers to deploy effective treatment solutions such as immunotherapy to stop and potentially reverse the serious and wide-ranging effects of allergy. They maintain that immunotherapy is currently the only medical intervention that can potentially affect the natural course of the disease.

Statistics cited in the publication indicate that more than 150 million people in Europe are afflicted with allergy, with the EAACI predicting that in less than 15 years more than half of the European population will suffer from some type of allergy.

The document also contains useful descriptions of allergic disease, immunotherapy and health economics in relation to allergy, along with quality of life information and patient anecdotes.

The 28 page, 5MB pdf file can be downloaded from the eaaci website.